(Logo: http://photos.prnewswire.com/prnh/20120502/529202-a http://photos.prnewswire.com/prnh/20120502/529202-a>)
The company's revolutionary PROcedure Rehearsal Studio™ (PRS) http://simbionix.com/clinical-rehearsal/> steps up simulation by enabling physicians to rehearse a complete endovascular procedure on a virtual 3D anatomical model based on a specific patient's CT data. The virtual model can be used for simulating, analyzing and evaluating pre-operative surgical treatment options prior to performing an actual case, which may increase a physician's confidence in the upcoming procedure.
The advantages of patient specific planning have long been recognized in other fields within the healthcare industry, such as medical imaging. Simbionix is pleased to announce the signing of a collaboration agreement with the market leader in medical image analysis software,
The collaboration will enable exporting the 3mensio Vascular™ model into the Simbionix simulation environment to form a comprehensive planning solution that combines 3DR, data analysis and simulation on the same platform. The solution will allow physicians and clinical specialists to rehearse a procedure in a complete virtual environment without the need for physical tools. This will take users of the 3mensio software to the next level of preparedness for endovascular procedures, as it will allow added simulation insights. Cases created by the software may also be imported to theANGIO Mentor simulator http://simbionix.com/simulators/angio-mentor/> for full procedure practice http://simbionix.com/simulators/angio-mentor/library-of-modules/> using fluoroscopy, guidewires, catheters, and other equipment that is used in the cath lab.
Simbionix recently received the CE marking of conformity for its patient specific simulation, an important step towards launching this innovative technology and expansion of its use in the clinical practice. The PRS CE mark demonstrates the product's compliance with stringent requirements related to the quality, safety, and performance of medical devices determined by the
In addition, Simbionix PRS has recently been granted a patent in
Visit: http://www.simbionix.com http://www.simbionix.com/>, Facebook https://www.facebook.com/pages/Simbionix/328515966636>, Twitter https://twitter.com/SimbionixUSA> and LinkedIn http://www.linkedin.com/company/35459>.
Most Popular Stories
- Bently Creates Alabama Small Business Commission
- When to Say No to Investors, Yes to Mentors
- Bolivar Appointed to NSHMBA National Board
- Rosneft Growth Slowed by Western Sanctions
- SBA Kicks off Hispanic Heritage Month
- Duke Energy, Strata Partner on Big Solar Project
- Lindsay Lohan Claims She Handled Whitney Houston's Body Bag
- Ukraine Offers Temporary Autonomy to Rebel-held Areas
- Cat Stevens Touring U.S., First Since 1970s
- Thousands Risk Losing Health Care Aid